The first Onconova Therapeutics trade was made in Q4 2018.
Since then Ken Griffin bought shares six more times and sold shares on ten occasions. The investor completely sold their stake between Q3 2022 and Q1 2023.
Avg closing price
Price range
Sold -18.7 Thousand shares
Q1 2023
Avg closing price
$0.87
Price range
$0.69
-
$1.42
Sold 56.3% shares (-24.1 Thousand shares)
Q4 2022
Avg closing price
$0.75
Price range
$0.63
-
$0.97
Sold 28.2% shares (-16.8 Thousand shares)
Q3 2022
Avg closing price
$1.21
Price range
$0.88
-
$1.45
New holding (+59.5 Thousand shares)
Q2 2022
Avg closing price
$1.35
Price range
$1.04
-
$1.90
Sold -40.6 Thousand shares
Q1 2022
Avg closing price
$1.85
Price range
$1.46
-
$2.82
Sold 42.5% shares (-30 Thousand shares)
Q4 2021
Avg closing price
$3.22
Price range
$2.49
-
$3.73
New holding (+70.6 Thousand shares)
Q3 2021
Avg closing price
$5.15
Price range
$3.81
-
$6.76
Sold -3.87 Thousand shares
Q2 2021
Avg closing price
$9.05
Price range
$6.28
-
$16.20
Sold 79.9% shares (-15.3 Thousand shares)
Q1 2021
Avg closing price
$15.09
Price range
$7.52
-
$26.40
New holding (+19.2 Thousand shares)
Q3 2020
Avg closing price
$9.96
Price range
$3.11
-
$20.85
Sold -12.1 Thousand shares
Q2 2020
Avg closing price
$6.11
Price range
$4.17
-
$9.21
Increased shares by 212.2% (+8.2 Thousand shares)
Q1 2020